2Commencement#
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 October 2026 | 1 October 2026 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
4 Schedules#
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1 · Amendments
National Health (Pharmaceutical Benefits) (Pharmacist Substitution of
Medicines without Prescription during Shortages) Determination 2021
1 Subsection 5(8), after item dealing with dapsone
Insert:
| 17 | Listed drug: DiltiazemForm: Capsule (controlled delivery) containing diltiazem hydrochloride 360 mgManner of administration: OralBrand: Vasocardol CD | Listed drug: DiltiazemForm: Capsule (controlled delivery) containing diltiazem hydrochloride 180 mgManner of administration: OralBrand: any of the following: |
Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.